{"count": 4, "results": [{"_id": "35131168", "pmid": 35131168, "title": "Clinical profiling and screening for HNF4alpha and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).", "journal": "Prim Care Diabetes", "authors": ["Firdous P", "Hassan T", "Nissar K", "Masoodi SR", "Ganai BA"], "date": "2022-04-01T00:00:00Z", "doi": "10.1016/j.pcd.2022.01.007", "meta_date_publication": "2022 Apr", "meta_volume": "16", "meta_issue": "2", "meta_pages": "325-332", "score": 50277.31, "text_hl": "On diagnosis, no @<m>DISEASE_Mason_Type_Diabetes</m> @DISEASE_MESH:C562772 @@@MODY@@@ @SPECIES_9606 @@@patient@@@ was given immediate @GENE_INS @GENE_3630 @@@insulin@@@; instead, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (68%) or @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonyl-urea@@@ (28%) and dietary changes (4%) were recommended. ", "citations": {"NLM": "Firdous P, Hassan T, Nissar K, Masoodi SR, Ganai BA. Clinical profiling and screening for HNF4alpha and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY). Prim Care Diabetes. 2022 Apr;16(2):325-332. PMID: 35131168", "BibTeX": "@article{35131168, title={Clinical profiling and screening for HNF4alpha and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).}, author={Firdous P and Hassan T and Nissar K and Masoodi SR and Ganai BA}, journal={Prim Care Diabetes}, volume={16}, number={2}, pages={325-332}}"}}, {"_id": "40585621", "pmid": 40585621, "title": "Type 2 Diabetes Mellitus Diagnosed at the Age of Eight Years: A Case Report.", "journal": "Cureus", "authors": ["Hasan MR", "Hasan M", "Aharama A"], "date": "2025-05-29T00:00:00Z", "doi": "10.7759/cureus.85065", "meta_date_publication": "2025 May", "meta_volume": "17", "meta_issue": "5", "meta_pages": "e85065", "score": 50232.68, "text_hl": "As his @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ was an important issue, we initiated semaglutide at a dose of 0.25 mg later on. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ was stopped due to @DISEASE_Dyspepsia @DISEASE_MESH:D004415 @@@dyspepsia@@@. ", "citations": {"NLM": "Hasan MR, Hasan M, Aharama A. Type 2 Diabetes Mellitus Diagnosed at the Age of Eight Years: A Case Report. Cureus. 2025 May;17(5):e85065. PMID: 40585621", "BibTeX": "@article{40585621, title={Type 2 Diabetes Mellitus Diagnosed at the Age of Eight Years: A Case Report.}, author={Hasan MR and Hasan M and Aharama A}, journal={Cureus}, volume={17}, number={5}, pages={e85065}}"}}, {"_id": "29180640", "pmid": 29180640, "pmcid": "PMC5703958", "title": "Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients", "journal": "Sci Rep", "authors": ["Li FF", "Liu BL", "Yin GP", "Zhang DF", "Zhai XF", "Chen MY", "Su XF", "Wu JD", "Ye L", "Ma JH"], "date": "2017-11-27T00:00:00Z", "doi": "10.1038/s41598-017-16658-x", "meta_date_publication": "2017 Nov 27", "meta_volume": "7", "meta_issue": "1", "meta_pages": "16382", "score": 50067.105, "text_hl": "A total of 95 @SPECIES_9606 @@@patients@@@ (19 with @<m>DISEASE_Mason_Type_Diabetes</m> @DISEASE_MESH:C562772 @@@YOD@@@ and 76 with @DISEASE_Diabetic_Neuropathies @DISEASE_MESH:D003929 @@@LOD@@@) received the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ add-on therapy. ", "citations": {"NLM": "Li FF, Liu BL, Yin GP, Zhang DF, Zhai XF, Chen MY, Su XF, Wu JD, Ye L, Ma JH. Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients Sci Rep. 2017 Nov 27;7(1):16382. PMID: 29180640", "BibTeX": "@article{29180640, title={Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients}, author={Li FF and Liu BL and Yin GP and Zhang DF and Zhai XF and Chen MY and Su XF and Wu JD and Ye L and Ma JH}, journal={Sci Rep}, volume={7}, number={1}, pages={16382}}"}}, {"_id": "23014256", "pmid": 23014256, "title": "Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.", "journal": "Diabetes Metab Syndr", "authors": ["Kota SK", "Meher LK", "Jammula S", "Kota SK", "Modi KD"], "date": "2012-01-01T00:00:00Z", "doi": "10.1016/j.dsx.2012.05.014", "meta_date_publication": "2012 Jan-Mar", "meta_volume": "6", "meta_issue": "1", "meta_pages": "54-8", "score": 50053.875, "text_hl": "More recently, studies reported variants within a novel gene, @GENE_TCF7L2 @GENE_6934 @@@TCF7L2@@@, as a putative susceptibility gene for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ across many ethnic backgrounds around the world. @<m>DISEASE_Mason_Type_Diabetes</m> @DISEASE_MESH:C562772 @@@MODY@@@ @SPECIES_9606 @@@patients@@@ respond better to @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonylureas@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, while @DISEASE_Diabetes_Mellitus_Transient_Neonatal_1 @DISEASE_MESH:C563322 @@@neonatal diabetes@@@ @SPECIES_9606 @@@patients@@@ with genetic mutations can be changed from @GENE_INS @GENE_3630 @@@insulin@@@ to oral drugs. ", "citations": {"NLM": "Kota SK, Meher LK, Jammula S, Kota SK, Modi KD. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities. Diabetes Metab Syndr. 2012 Jan-Mar;6(1):54-8. PMID: 23014256", "BibTeX": "@article{23014256, title={Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.}, author={Kota SK and Meher LK and Jammula S and Kota SK and Modi KD}, journal={Diabetes Metab Syndr}, volume={6}, number={1}, pages={54-8}}"}}]}